SRPL — Shreeram Proteins Balance Sheet
0.000.00%
- IN₹282.74m
- IN₹663.98m
Annual balance sheet for Shreeram Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 9.97 | 313 | 0.425 | 0.97 | 0.136 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 434 | 80.1 | 281 | 237 | 236 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 925 | 1,091 | 988 | 920 | 732 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 74.1 | 67.7 | 70.3 | 55.7 | 49 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,001 | 1,160 | 1,061 | 983 | 787 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 417 | 531 | 421 | 414 | 398 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 540 | 638 | 500 | 518 | 532 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 461 | 522 | 561 | 465 | 255 |
| Total Liabilities & Shareholders' Equity | 1,001 | 1,160 | 1,061 | 983 | 787 |
| Total Common Shares Outstanding |